1059 |
Is Protection Device Really Harmful? - Does the Type of Protection Device Matter ? |
Issam D. Moussa |
May. 12. 11 |
1058 |
Does CREST Trial Change the Practice of Symptomatic Carotid Stenosis |
Andrej Schmidt |
May. 12. 11 |
1057 |
Tailored Approach for Carotid Lesion Morphology Alone |
John R. Laird |
May. 12. 11 |
1056 |
Endurant: 2 Year Single Center Experience and Results from Clinical Studies |
Philippe Cuypers |
May. 12. 11 |
1055 |
Dynamic and Static Organ Malperfusion: Preferred Endovascular Solution |
Hyun-Ki Yoon |
May. 12. 11 |
1054 |
Identifying Complications and Its Management of Open and Endovascular AAA Repair |
Richard R. Heuser |
May. 12. 11 |
1053 |
Challenging AAA Anatomy and Endovascular Management |
Kishore Sieunarine |
May. 12. 11 |
1052 |
New Horizon: Drug-eluting Balloon or Stent for Infrepopliteal Lesions |
Andrej Schmidt |
May. 12. 11 |
1051 |
Antegrade or Retrograde? Single or Multiple Vessels? Paradigms and Practice of Infrapopliteal Endovascular Revascularization |
Sven Braunlich |
May. 12. 11 |
1050 |
BTK Intervention: Its Results and How to Maximize Outcomes in Pre-drug-eluting Era ? |
Gian Battista Danzi |
May. 12. 11 |